430 related articles for article (PubMed ID: 22101076)
1. Pharmacological antioxidant strategies as therapeutic interventions for COPD.
Rahman I
Biochim Biophys Acta; 2012 May; 1822(5):714-28. PubMed ID: 22101076
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and dietary antioxidant therapies for chronic obstructive pulmonary disease.
Biswas S; Hwang JW; Kirkham PA; Rahman I
Curr Med Chem; 2013; 20(12):1496-530. PubMed ID: 22963552
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant therapies in COPD.
Rahman I
Int J Chron Obstruct Pulmon Dis; 2006; 1(1):15-29. PubMed ID: 18046899
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant therapeutic targets in COPD.
Rahman I; Kilty I
Curr Drug Targets; 2006 Jun; 7(6):707-20. PubMed ID: 16787173
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant therapeutic advances in COPD.
Rahman I
Ther Adv Respir Dis; 2008 Dec; 2(6):351-74. PubMed ID: 19124382
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant pharmacological therapies for COPD.
Rahman I; MacNee W
Curr Opin Pharmacol; 2012 Jun; 12(3):256-65. PubMed ID: 22349417
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Potential of Small Molecules Targeting Oxidative Stress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD): A Comprehensive Review.
Dailah HG
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080309
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and redox regulation of lung inflammation in COPD.
Rahman I; Adcock IM
Eur Respir J; 2006 Jul; 28(1):219-42. PubMed ID: 16816350
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants and mucolytics in COPD management: when (if ever) and in whom?
Hillas G; Nikolakopoulou S; Hussain S; Vassilakopoulos T
Curr Drug Targets; 2013 Feb; 14(2):225-34. PubMed ID: 23256719
[TBL] [Abstract][Full Text] [Related]
10. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
Cazzola M; Page CP; Wedzicha JA; Celli BR; Anzueto A; Matera MG
Respir Res; 2023 Jul; 24(1):194. PubMed ID: 37517999
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-based therapeutics in COPD.
Barnes PJ
Redox Biol; 2020 Jun; 33():101544. PubMed ID: 32336666
[TBL] [Abstract][Full Text] [Related]
12. Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease.
Rahman I; Kinnula VL
Expert Rev Clin Pharmacol; 2012 May; 5(3):293-309. PubMed ID: 22697592
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Rogliani P; Matera MG; Page C; Puxeddu E; Cazzola M; Calzetta L
Respir Res; 2019 May; 20(1):104. PubMed ID: 31133026
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
Rahman I
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
[TBL] [Abstract][Full Text] [Related]
16. Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis
Sun X; Feng X; Zheng D; Li A; Li C; Li S; Zhao Z
Clin Sci (Lond); 2019 Jul; 133(13):1523-1536. PubMed ID: 31270147
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
18. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1.
Malhotra D; Thimmulappa R; Navas-Acien A; Sandford A; Elliott M; Singh A; Chen L; Zhuang X; Hogg J; Pare P; Tuder RM; Biswal S
Am J Respir Crit Care Med; 2008 Sep; 178(6):592-604. PubMed ID: 18556627
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.
Rahman I
Treat Respir Med; 2005; 4(3):175-200. PubMed ID: 15987234
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin gallate diminishes cigarette smoke-induced oxidative stress, lipid peroxidation, and inflammation in human bronchial epithelial cells.
Lakshmi SP; Reddy AT; Kodidhela LD; Varadacharyulu NC
Life Sci; 2020 Oct; 259():118260. PubMed ID: 32795541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
